News

News

No. Title Written by Date Read
13 STCube signs additional development and manufacturing agreement with Samsung Biologics Admin 20.07.12 2
12 STCube Presents Data on Its Proprietary PD-1 Antibody at AACR Admin 20.06.23 5
11 STCube Applies for a U.S. Patent on the COVID-19 Anti-viral Treatment Using 'STT-003' Admin 20.03.30 2
10 STCube Initiates a CRO Contract for Development of COVID-19 Treatment Using ‘STT-003’ Admin 20.03.23 2
9 STCube Publishes Research Paper on Its Antibody to Immune-checkpoint Inhibitor PD-1 in Cancer Research, an International Academic Journal Admin 20.03.12 2
8 STCube and Samsung Biologics Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug Admin 20.03.03 2
7 STCube Obtains EU Patent for Screening Method for Cancer Immunotherapy Candidates Using Radiation Admin 19.11.28 2
6 STCube Attracts Investment of 42 Billion Won, “Accelerating Development of Anti-cancer Immunotherapies Admin 18.04.25 3
5 A Road to Conquering Cancer — Successful Development of Antibody Drug as Potential Cure for Difficult-to-Treat Cancer Admin 18.02.13 2
4 Global Patent Application Made for STCube’s Novel Anti-cancer Immunotherapy Admin 17.11.23 4